1 |
Ocr |
- |
- |
- |
- |
013 1件: 13 💬 |
2 |
Ocrelizumab |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 3件: 13, 46, 49 💬 |
3 |
Ocrelizumab / rhumab 2h7 |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
4 |
Ocrelizumab 300 mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
5 |
Ocrelizumab 300mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
6 |
Ocrelizumab 300mg /10ml |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
7 |
Ocrelizumab 300mg/10 ml |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
8 |
Ocrelizumab 300mg/10ml |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
9 |
Ocrelizumab 500mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
10 |
Ocrelizumab 600 mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
11 |
Ocrelizumab at home |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
12 |
Ocrelizumab dose 1 |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
13 |
Ocrelizumab dose 2 and dose 3 |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
14 |
Ocrelizumabu 200mg |
- |
- |
- |
- |
046 1件: 46 💬 |
15 |
Ocrelizumabu 50mg |
- |
- |
- |
- |
046 1件: 46 💬 |
16 |
Ocrevus |
- |
- |
- |
- |
013 1件: 13 💬 |
17 |
Ocrrelizumab 300 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
18 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
19 |
Ovine corticotropin-releasing hormone (ocrh) |
Corticorelin |
2件: D00146 D00146, D03905 D03905 💬 |
CRHR1 3件: CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |